Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sunitinib versus Pazopanib Dilemma in Renal Cell Carcinoma: New Insights into the In Vitro Metabolic Impact, Efficacy, and Safety
Filipa Amaro, Carolina Pisoeiro, Maria João Valente, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9898-9898
Open Access | Times Cited: 10

Showing 10 citing articles:

Sunitinib induces cardiotoxicity through modulating oxidative stress and Nrf2-dependent ferroptosis in vitro and in vivo
Dongjie Li, Chengzhu Song, Chunpu Song, et al.
Chemico-Biological Interactions (2023) Vol. 388, pp. 110829-110829
Closed Access | Times Cited: 10
Cisplatin-Resistant Urothelial Bladder Cancer Cells Undergo Metabolic Reprogramming beyond the Warburg Effect
Julieta Afonso, Catarina Barbosa-Matos, Ricardo Silvestre, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1418-1418
Open Access | Times Cited: 1
A new perspective: deciphering the aberrance and clinical implication of disulfidptosis signatures in clear cell renal cell carcinoma
Bohong Chen, Mingguo Zhou, Li Guo, et al.
Aging (2024) Vol. 16, Iss. 11, pp. 10033-10062
Open Access | Times Cited: 1
Targeted DNA damage repair: old mechanisms and new opportunities in clear cell renal cell carcinoma
Jiahua Lv, Pengcheng Gong, Gongwei Jia, et al.
Genome Instability & Disease (2024)
Closed Access | Times Cited: 1
Metformin Regulates the miR-205/VEGFA Axis in Renal Cell Carcinoma Cells: Exploring a Clinical Synergism with Tyrosine Kinase Inhibitors
Markus Krebs, Mischa J. Kotlyar, Julian Fahl, et al.
Urologia Internationalis (2023) Vol. 108, Iss. 1, pp. 49-59
Open Access | Times Cited: 2
Exploring the anticancer potential of hydrogen sulfide and BAY‑876 on clear cell renal cell carcinoma cells: Uncovering novel mutations in VHL and KDR genes among ccRCC patients
Peshraw S. Hamadamin, Kalthum Asaaf Maulood
Molecular and Clinical Oncology (2024) Vol. 20, Iss. 3
Open Access
Metabolomics Reveals Tyrosine Kinase Inhibitor Resistance-Associated Metabolic Events in Human Metastatic Renal Cancer Cells
Filipa Amaro, Márcia Carvalho, Maria de Lourdes Bastos, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6328-6328
Open Access
Impact of the redox-active MnTnHex-2-PyP5+ and cisplatin on the metabolome of non-small cell lung cancer cells
Rita B. Soares, Joana Pinto, Filipa Amaro, et al.
Biochemical Pharmacology (2024) Vol. 227, pp. 116424-116424
Open Access
Prognostic value of type of prior TKI in pretreated metastatic renal cell carcinoma patients receiving nivolumab
Alessandra Damassi, Malvina Cremante, Alessio Signori, et al.
Immunotherapy (2024) Vol. 16, Iss. 18-19, pp. 1095-1103
Closed Access
Activation of HSPA5 contributes to pazopanib-induced hepatotoxicity through l-ornithine metabolism pathway and endoplasmic reticulum stress
Jian Chen, Tieming Zhu, Ya-Ping Deng, et al.
Journal of Pharmacy and Pharmacology (2024)
Closed Access
Page 1

Scroll to top